Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomics provides individualized options of precision medicine for patients with gastric cancer.
Huang W, Zhan D, Li Y, Zheng N, Wei X, Bai B, Zhang K, Liu M, Zhao X, Ni X, Xia X, Shi J, Zhang C, Lu Z, Ji J, Wang J, Wang S, Ji G, Li J, Nie Y, Liang W, Wu X, Cui J, Meng Y, Cao F, Shi T, Zhu W, Wang Y, Chen L, Zhao Q, Wang H, Shen L, Qin J. Huang W, et al. Among authors: zheng n. Sci China Life Sci. 2021 Aug;64(8):1199-1211. doi: 10.1007/s11427-021-1966-4. Epub 2021 Jul 9. Sci China Life Sci. 2021. PMID: 34258712
[Urine proteomics signatures associated with alcohol drinking among residents attending the National Upper Gastrointestinal Cancer Early Detection Program in Linqu, Shandong province].
Fan H, Li X, Zheng NR, Huang S, Zhou T, Li ZX, Zhang Y, Zhang JY, You WC, Pan KF, Li WQ. Fan H, et al. Among authors: zheng nr. Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Sep 6;55(9):1139-1144. doi: 10.3760/cma.j.cn112150-20210312-00247. Zhonghua Yu Fang Yi Xue Za Zhi. 2021. PMID: 34619934 Chinese.
Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer.
Li X, Zheng NR, Wang LH, Li ZW, Liu ZC, Fan H, Wang Y, Dai J, Ni XT, Wei X, Liu MW, Li K, Li ZX, Zhou T, Zhang Y, Zhang JY, Kadeerhan G, Huang S, Wu WH, Liu WD, Wu XZ, Zhang LF, Xu JM, Gerhard M, You WC, Pan KF, Li WQ, Qin J. Li X, et al. EBioMedicine. 2021 Dec;74:103714. doi: 10.1016/j.ebiom.2021.103714. Epub 2021 Nov 22. EBioMedicine. 2021. PMID: 34818622 Free PMC article.
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes.
Tang M, Zhao Y, Zhao J, Wei S, Liu M, Zheng N, Geng D, Han S, Zhang Y, Zhong G, Li S, Zhang X, Wang C, Yan H, Cao X, Li L, Bai X, Ji J, Feng XH, Qin J, Liang T, Zhao B. Tang M, et al. Among authors: zheng n. Sci Adv. 2022 Jun 24;8(25):eabn5683. doi: 10.1126/sciadv.abn5683. Epub 2022 Jun 22. Sci Adv. 2022. PMID: 35731873 Free PMC article.
Expanding individualized therapeutic options via genoproteomics.
Zhan D, Zheng N, Zhao B, Cheng F, Tang Q, Liu X, Wang J, Wang Y, Liu H, Li X, Su J, Zhong X, Bu Q, Cheng Y, Wang Y, Qin J. Zhan D, et al. Among authors: zheng n. Cancer Lett. 2023 Apr 28;560:216123. doi: 10.1016/j.canlet.2023.216123. Epub 2023 Mar 11. Cancer Lett. 2023. PMID: 36907503 Free article.
2,269 results